Q2 FY2026 EarningsQ2 FY26 beat consensus across all key financial metrics, with revenue of $3,873M vs. $3,663M expected and adjusted EPS of $0.45 vs. $0.398 expected. Growth was primarily driven by a 22% increase in revenue per script in Pharmacy Solutions and a 54% increase in Home Health Care daily census. Full-year FY26 revenue and Adjusted EBITDA guidance was raised, reflecting strong momentum and effective operational execution following the Community Living divestiture.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BrightSpring Health Services(BTSG) the Revenue is 3.873 B (+23.05%), Beat estimate;the EBIT is 164.08 M (+62.98%), Beat estimate;the EPS is 0.38 (+192.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.87B23.05%
3.66B16.38%
+0.21B6.67%
EBITExceed expectations
0.16B62.98%
0.14B42.47%
+0.02B20.51%
EPSExceed expectations
0.38192.31%
0.3171143.95%
+0.062948.36%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf